EPM Scientific

  When it comes to medical devices, what's the cost of quality? It could be as much as $36 billion, according to research by McKinsey & Company which suggests the total direct cost of quality is between 6.8% and 9.4% of industry sales. [1]   That’s equivalent to between $26 billion and $36 billion each year. One-third of that amount is ensuring good quality, the remaining two-thirds is the direct cost of poor quality. Global sales of medical devices reached $380 billion last year, rising from $260 billion in 2006 [1]   – but during that time, the quality of these devices failed to keep pace.   The industry has realized it needs to do more to capture the value of good quality in medical devices. The growth in demand for medical devices The medical device industry is worth $140 billion in the US, making it the largest medical device consumer in the world. [2]   The industry encompasses more than 5,800 companies in the US alone (80% of which employ fewer than 5...

  With a rapidly evolving business climate on the horizon, how can firms be agile, innovative, and sharpen their operational capabilities to remain at the competitive edge of Life Sciences? It begins by  reimagining the future through talent.   By placing talent at the heart of business decisions and growth strategies, Life Sciences players can better prepare for tomorrow’s challenges and change the dial of their success.    The definitive guide:  ‘ Reimagine the Future Through Talent ’  gives a glimpse into the current state of the Asian Pacific Life Sciences market and provides a framework for crafting a talent-driven corporation.

  EPM Scientific’s parent company,   Phaidon International , has recently revealed the launch of Larson Maddox – a specialist subsidiary talent partner for the Regulatory and Legal market.  Adding to the group portfolio, Larson Maddox sharpens the award-winning firm’s service offering and provides a platform for exponential growth.  Phaidon International Group COO,  Steve Yendell , comments, “In response to consistent demand from our client partners and candidate network, we are launching Larson Maddox to focus exclusively on the regulatory and legal talent challenges across a broad range of sectors.” He continues, “Larson Maddox complements our existing specialist brand portfolio perfectly by enabling us to help clients from all sectors secure talent to navigate the rapidly evolving Regulatory and Legal landscape.”   For Phaidon International, the creation of a dedicated brand is imperative to support their clients whose rapid growth in key industry verticals must be met...